Scenarios that move MIRM

Mirum Pharmaceuticals, Inc. - common stock

Scenarios that move MIRM: 2 analyses, 2 positive, 0 negative.

1. 2026-10-13 · Mirum's Livmarli meets Phase III goal in ultra-rare liver diseases — ▲ · impact +88 · confidence high · horizon immediate
2. 2026-09-29 · Mirum's Brelovitug meets goal in Phase III AZURE-1 study — ▲ · impact +90 · confidence high · horizon immediate

All scenarios · Run a scenario · Pricing